Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Dorado, PR
SEC filing record 1 source field available
Fiscal year end
31 October
Pharma-Bio Serv, Inc. has filed 524 SEC EDGAR filings since 24 Sep 2004

SEC filing history

Showing 26-50 of 373 matching filings.

Per page
25
Current page
2
4

PRIMARY DOCUMENT

Filing date
14 Jan 2025
Reporting date
10 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
14 Jan 2025
Reporting date
10 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
14 Jan 2025
Reporting date
10 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
14 Jan 2025
Reporting date
10 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 000-50956

ARS

Filing date
08 Apr 2024
Reporting date
31 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-50956

DEF 14A

Filing date
08 Apr 2024
Reporting date
04 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Jan 2024
Reporting date
10 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Jan 2024
Reporting date
10 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Jan 2024
Reporting date
10 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Jan 2024
Reporting date
10 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
09 Jan 2024
Reporting date
05 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
09 Jan 2024
Reporting date
05 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
28 Dec 2023
Reporting date
26 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .